Morgan Stanley’s BioCardia BCDA Stock Holding History

Morgan Stanley’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.85K	Hold	3,105	–	–	﹤0.01%	7268
2026 Q1	$3.76K	Hold	3,105	–	–	﹤0.01%	7208
2025 Q4	$3.88K	Hold	3,105	–	–	﹤0.01%	7113
2025 Q3	$4K	Hold	3,105	–	–	﹤0.01%	7151
2025 Q2	$6.05K	Hold	3,105	–	–	﹤0.01%	6987
2025 Q1	$7.89K	Sell	3,105 -911	-23%	-$2.2K	﹤0.01%	6873
2024 Q4	$8.76K	Buy	4,016 +3,986	+13,287%	+$9.34K	﹤0.01%	6855
2024 Q3	$94	Hold	30	–	–	﹤0.01%	7450
2024 Q2	$89	Hold	30	–	–	﹤0.01%	7376
2024 Q1	$183	Hold	30	–	–	﹤0.01%	7321
2023 Q4	$299	Sell	30 -36	-55%	-$292	﹤0.01%	7259
2023 Q3	$423	Hold	66	–	–	﹤0.01%	7323
2023 Q2	$2.63K	Hold	66	–	–	﹤0.01%	7136
2023 Q1	$1.92K	Hold	66	–	–	﹤0.01%	7244
2022 Q4	$2.05K	Hold	66	–	–	﹤0.01%	7366
2022 Q3	$2K	Hold	66	–	–	﹤0.01%	7446
2022 Q2	$1K	Hold	66	–	–	﹤0.01%	7657
2022 Q1	$2K	Hold	66	–	–	﹤0.01%	7723
2021 Q4	$2K	Sell	66 -26	-28%	-$954	﹤0.01%	7780
2021 Q3	$4K	Hold	92	–	–	﹤0.01%	7534
2021 Q2	$5K	Buy	92 +26	+39%	+$1.58K	﹤0.01%	7370
2021 Q1	$4K	Hold	66	–	–	﹤0.01%	7141
2020 Q4	$3K	Buy	66 +30	+83%	+$1.2K	﹤0.01%	6838
2020 Q3	$1K	Hold	36	–	–	﹤0.01%	6645
2020 Q2	$1K	Sell	36 -43	-54%	-$2.33K	﹤0.01%	6510
2020 Q1	$4K	Hold	79	–	–	﹤0.01%	6259
2019 Q4	$4K	Buy	79 +43	+119%	+$2.53K	﹤0.01%	6416
2019 Q3	$2K	Buy	+36	New	+$2.58K	﹤0.01%	6467

Other funds holding BCDA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Morgan Stanley's BCDA Position: Q2 2026 in Review

Morgan Stanley held its BioCardia (BCDA) position steady in Q2 2026 at 3,105 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #7268.

Morgan Stanley first reported a position in BCDA in Q3 2019 and has held it in 28 quarters since. The position peaked at $8.76K in Q4 2024. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

Morgan Stanley held 3,105 shares of BioCardia worth $3.85K as of Q2 2026.
Morgan Stanley left its BioCardia share count unchanged in Q2 2026.
BioCardia made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7268 holding.
Morgan Stanley first reported a position in BioCardia in Q3 2019 and has held it in 28 quarters since.
Morgan Stanley's BioCardia position peaked at $8.76K in Q4 2024.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.